• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VM-PATHI 与前庭性偏头痛患者成功治疗后的认知功能改善相关。

VM-PATHI Correlates With Cognitive Function Improvement After Successful Treatment in Patients With Vestibular Migraine.

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco.

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, California.

出版信息

Otol Neurotol. 2023 Sep 1;44(8):813-816. doi: 10.1097/MAO.0000000000003976. Epub 2023 Jul 29.

DOI:10.1097/MAO.0000000000003976
PMID:37525385
Abstract

OBJECTIVE

To assess changes in cognitive function in vestibular migraine patients undergoing treatment.

STUDY DESIGN

Prospective cohort.

SETTING

Single-institution tertiary-care center.

PATIENTS

Thirty-four patients with vestibular migraine were included in the study. Average age at diagnosis was 47.9 years. A majority of patients (91.2%) were female.

INTERVENTIONS

Vestibular therapies included pharmacologic treatment (67.6%), mindfulness-based stress reduction (58.8%), vestibular physical therapy (20.6%), and lifestyle changes only (2.9%).

MAIN OUTCOME MEASURES

Pretreatment and posttreatment questionnaires were collected including the Cognitive Failures Questionnaire (CFQ), Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI), and Dizziness Handicap Inventory.

RESULTS

Median time between pretreatment and posttreatment questionnaire was 4.4 months (range, 2.8-15.6. mo). CFQ scores decreased in subjects who responded to treatment, as defined by those with a positive change in VM-PATHI score (average decrease, 6.5; p = 0.03). CFQ scores did not improve in subjects who had no improvement in their vestibular condition, as defined by no change or an increase in VM-PATHI score (average increase, 2.0; p = 0.53). Univariate linear regression showed that VM-PATHI score change was highly predictive of CFQ change ( p < 0.01, r2 = 0.36). Multivariate regression demonstrated that the VM-PATHI ( p = 0.03) and not the Dizziness Handicap Inventory ( p = 0.10) predicted changes in CFQ score.

CONCLUSIONS

Self-reported cognitive dysfunction improves with successful treatment of vestibular migraine.

摘要

目的

评估前庭性偏头痛患者接受治疗后认知功能的变化。

研究设计

前瞻性队列研究。

设置

单机构三级护理中心。

患者

34 例前庭性偏头痛患者纳入本研究。诊断时的平均年龄为 47.9 岁。大多数患者(91.2%)为女性。

干预措施

前庭治疗包括药物治疗(67.6%)、正念减压(58.8%)、前庭物理治疗(20.6%)和仅生活方式改变(2.9%)。

主要观察指标

收集治疗前和治疗后问卷,包括认知失败问卷(CFQ)、前庭偏头痛患者评估工具和残疾量表(VM-PATHI)以及头晕残疾量表。

结果

治疗前和治疗后问卷中位数时间间隔为 4.4 个月(范围,2.8-15.6 个月)。根据 VM-PATHI 评分变化定义的对治疗有反应的患者(平均变化,6.5;p=0.03),CFQ 评分降低。根据 VM-PATHI 评分无变化或增加(平均增加,2.0;p=0.53)定义的前庭状况无改善的患者,CFQ 评分未改善。单变量线性回归显示,VM-PATHI 评分变化与 CFQ 变化高度相关(p<0.01,r2=0.36)。多元回归表明,VM-PATHI(p=0.03)而不是头晕残疾量表(p=0.10)预测 CFQ 评分变化。

结论

前庭性偏头痛成功治疗后,自我报告的认知功能障碍得到改善。

相似文献

1
VM-PATHI Correlates With Cognitive Function Improvement After Successful Treatment in Patients With Vestibular Migraine.VM-PATHI 与前庭性偏头痛患者成功治疗后的认知功能改善相关。
Otol Neurotol. 2023 Sep 1;44(8):813-816. doi: 10.1097/MAO.0000000000003976. Epub 2023 Jul 29.
2
Correlating Vestibular Migraine Patient Assessment Tool and Handicap Inventory to Daily Dizziness Symptoms.将前庭性偏头痛患者评估工具与失能问卷相关联,以评估日常头晕症状。
Otol Neurotol. 2023 Dec 1;44(10):1052-1056. doi: 10.1097/MAO.0000000000004014. Epub 2023 Sep 15.
3
Minimal Clinically Important Difference of Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI).前庭性偏头痛患者评估工具与功能障碍量表(VM-PATHI)的最小临床重要差异
Otolaryngol Head Neck Surg. 2025 Feb;172(2):623-628. doi: 10.1002/ohn.1035. Epub 2024 Oct 30.
4
Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) : A narrative review.前庭性偏头痛患者评估工具与功能障碍量表(VM-PATHI):一篇叙述性综述。
Headache. 2025 Mar;65(3):521-526. doi: 10.1111/head.14866. Epub 2024 Dec 30.
5
Development and Validation of VM-PATHI: Vestibular Migraine Patient Assessment Tool and Handicap Inventory.VM-PATHI 的制定与验证:前庭性偏头痛患者评估工具和失能量表。
Otol Neurotol. 2020 Apr;41(4):e494-e500. doi: 10.1097/MAO.0000000000002561.
6
The Role of Motion Sensitivity and Headaches on Vestibular Rehabilitation Outcomes in Pediatric Vestibular Migraines.运动敏感和头痛对儿童前庭性偏头痛前庭康复治疗效果的影响。
Otol Neurotol. 2024 Mar 1;45(3):e177-e185. doi: 10.1097/MAO.0000000000004120. Epub 2024 Feb 7.
7
Non-pharmacological interventions for prophylaxis of vestibular migraine.预防前庭性偏头痛的非药物干预措施。
Cochrane Database Syst Rev. 2023 Apr 12;4(4):CD015321. doi: 10.1002/14651858.CD015321.pub2.
8
Short-term effects of lifestyle modification on vestibular migraine.生活方式改变对前庭性偏头痛的短期影响。
Int J Audiol. 2025 Aug;64(8):853-860. doi: 10.1080/14992027.2024.2409763. Epub 2024 Oct 13.
9
Dizziness: When Is It Migraine, and When Is It Not?头晕:何时为偏头痛性头晕,何时并非如此?
Curr Neurol Neurosci Rep. 2025 Aug 5;25(1):56. doi: 10.1007/s11910-025-01442-6.
10
Effects of nonprescription therapies on vestibular migraine: a questionnaire-based observational study.非处方疗法对前庭性偏头痛的影响:一项基于问卷的观察性研究。
Intern Med J. 2024 Jun;54(6):916-924. doi: 10.1111/imj.16314. Epub 2024 Jan 10.

引用本文的文献

1
Warfarin use and vestibular dysfunction insights from NHANES data, network pharmacology, Mendelian randomization, and molecular docking.华法林的使用与前庭功能障碍:来自美国国家健康与营养检查调查(NHANES)数据、网络药理学、孟德尔随机化和分子对接的见解
Sci Rep. 2025 Apr 6;15(1):11748. doi: 10.1038/s41598-025-96681-5.
2
Mindfulness-Based Stress Reduction for the Treatment of Vestibular Migraine: A Prospective Pilot Study.基于正念减压疗法治疗前庭性偏头痛:一项前瞻性试点研究。
Cureus. 2025 Feb 18;17(2):e79225. doi: 10.7759/cureus.79225. eCollection 2025 Feb.
3
Why is vestibular migraine associated with many comorbidities?
为什么前庭性偏头痛与许多共病有关?
J Neurol. 2024 Dec;271(12):7422-7433. doi: 10.1007/s00415-024-12692-8. Epub 2024 Sep 20.